Skip to content

South Asians With Type 2 Diabetes at Risk for Depression

Community-Engaged Approach to Supporting South Asians With Type 2 Diabetes at Risk for Depression

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07219667
Enrollment
100
Registered
2025-10-22
Start date
2027-08-01
Completion date
2028-06-01
Last updated
2026-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Brief summary

This study will adapt a community health worker (CHW)-led Type 2 diabetes (T2D) intervention to include mental health and digital components using a trauma informed care approach, and test the feasibility and acceptability of this intervention to support South Asians with T2D at risk for depression.

Detailed description

Specific Aim 1: Examine factors associated with distress, poor mental health, and comorbid T2D and depression among South Asians to inform pilot study structure and content. Specific Aim 2: Adapt CHW-led T2D intervention to include mental health and digital components using a trauma-informed care approach and the ecological validity model. Specific Aim 3: Evaluate the feasibility and acceptability of a pilot CHW-led intervention to support participants with T2D who are at risk for depression.

Interventions

BEHAVIORALCHW-led T2D Intervention

CHW-led T2D intervention that includes mental health and digital health components.

Sponsors

NYU Langone Health
Lead SponsorOTHER
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

Aim 1 (Qualitative Component): * South Asian ethnicity based on self-report information * 18 years of age or older * Residing in NYC * Willingness and capacity to provide consent Aim 3: Pilot Intervention: * South Asian ethnicity based on patient demographic information * 18 to 75 years of age * Appointment for routine non-emergent primary care in the past 12 months * Diagnosis of Type 2 diabetes * Patient Health Questionnaire-9 (PHQ-9) score of ≥5 (mild to severe depression) * Residing in NYC * Willingness and capacity to provide consent

Exclusion criteria

Aim 1 (Qualitative Component): • Diagnosed cognitive deficits or limited decision-making capacity Aim 3: Pilot Intervention: * Pregnant at the time of screening * Type 1 diabetes or diabetes secondary to other conditions (e.g., steroid-induced, pancreatic insufficiency) * Malignancy or life-threatening illness with a life expectancy of \<5 years * Inability to perform unsupervised physical activity * Diagnosed cognitive deficits or limited decision-making capacity * Currently taking anti-depressant medication or receiving counseling services.

Design outcomes

Primary

MeasureTime frameDescription
Change in HbA1c LevelsBaseline, Month 3Change in glycated hemoglobin (HbA1c).
Change in Diabetes Distress Scale (DDS) ScoreBaseline, Month 3The Diabetes Distress Scale (DDS) is a 17-item psychological questionnaire designed to assess the emotional and psychological distress experienced by individuals with diabetes. Each item is rated on a scale of 0 to 6. The total score is calculated by summing up the scores of all 17 items and ranges from 0-102; higher scores indicate greater distress.
Change in Patient Health Questionnaire-9 (PHQ-9) ScoreBaseline, Month 3The PHQ-9 is a 9-item questionnaire to assess depressive symptoms. Each item is scored from 0 (not at all) to 3 (nearly every day). The total score ranges from 0 to 27. Higher scores indicate greater severity of depression.

Countries

United States

Contacts

CONTACTNaheed Ahmed, PhD
Naheed.Ahmed@nyulangone.org646-501-3751
PRINCIPAL_INVESTIGATORNaheed Ahmed, PhD

NYU Langone Health

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 20, 2026